Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Bank7 Corp. (BSVN)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-05
$58.44-2.00%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.13 → 5.59 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BSVN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Sustain dividend per share growth to at least $0.27 in 2026-Q1 | Dividends increased from $0.24 to $0.27 per share, showing strong shareholder returns. | Intact | Dividend per share falls below $0.24 in any quarter after 2026-Q1 | Dividend per share: $0.27 per share FY2026-Q2; GAAP. Published target: >=0.27 USD_PER_SHARE. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 10, 20260.27 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
BSVN is a small-cap regional bank with a growth and expansion thesis, rather than a clear turnaround. The long-term thesis is intact and recent company momentum has improved, but management’s progress on its priorities is mixed.
Valuation is tagged as stretched, with a durable premium versus peers and a modest positive expectations gap. Fragility is low, but the evidence does not explain in detail what specific operating assumptions support the premium.
Near term, recent results look strong: third-quarter net income rose from the prior quarter, loans grew, and an earnings beat was reported. However, net interest margin and net income were both below year-ago levels, and management has not yet reported longer-term benefits from its expansion plans. Near-term miss risk is described as low, though the company’s smaller size and recent peer misses are cautions.
Over the next few quarters, the thesis depends on continued loan growth, execution of the Southwest expansion, and progress toward stronger core earnings and margins. A guidance cut or rate cuts would be unfavorable, while continued earnings strength and higher guidance from sector bellwethers would support the sector backdrop.
For the next one to three years, BSVN combines improving recent momentum with a credible expansion effort, but the premium valuation leaves less room for weak execution. The thesis hinges on turning loan growth and expansion plans into durable earnings. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain EPS at or above $1.25 per share in 2026-Q1 |
| Dividends increased from $0.24 to $0.27 per share, showing strong shareholder returns. |
| Broken |
| EPS falls below $1.08 in any quarter after 2026-Q1 |
Diluted EPS: $1.06 per share FY2026-Q3; GAAP. Published target: >=1.25 USD_PER_SHARE. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 15, 20261.06 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Increase cash from operating activities to at least $16.65 million in 2026-Q1 | The recent acquisition boosts growth potential and cash flow. | Broken | Operating cash flow falls below $9 million in any quarter after 2026-Q1 | Cash from operations: $0 FY2026-Q3; GAAP. Published target: >=16.65 million USD. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 15, 20260 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stabilize or improve revenue beyond -15% decline expected in 2026 | A supporting condition in Bank7 Corp.'s published investment case. The stated target is Revenue decline no worse than -15% YoY. | Intact | Revenue declines more than 15% YoY in FY26 | Revenue growth: -8.14% FY2026-Q3; GAAP. Published target: Revenue decline no worse than -15% YoY. Annual target cannot be compared with a quarterly or TTM observation. Oct 15, 2026-8.144293 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.48 → $5.59 · observed estimates
$0.10B → $0.16B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-25 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-26 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-27 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-28 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-29 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-30 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-07-31 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-01 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-02 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-03 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-04 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-05 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-06 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-07 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-08 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-09 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-10 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-11 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-12 | $4.48 | $102,000,000 | 3 / 2 |
| 2026-08-13 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-14 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-15 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-16 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-17 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-18 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-19 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-20 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-21 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-22 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-23 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-24 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-25 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-26 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-27 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-28 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-29 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-30 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-08-31 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-01 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-02 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-03 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-04 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-05 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-06 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-07 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-08 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-09 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-10 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-11 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-12 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-13 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-14 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-15 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-16 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-17 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-18 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-19 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-20 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-21 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-22 | $4.48 | $101,081,667 | 2 / 1 |
| 2026-09-23 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-09-24 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-09-25 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-09-26 | $5.13 | $145,546,000 | 2 / 2 |
| 2026-09-27 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-09-28 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-09-29 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-09-30 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-01 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-02 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-03 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-04 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-05 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-06 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-07 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-08 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-09 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-10 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-11 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-12 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-13 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-14 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-15 | $5.13 | $145,546,000 | 2 / 1 |
| 2026-10-16 | $5.59 | $164,607,333 | 2 / 1 |
| 2026-10-17 | $5.59 | $164,607,333 | 2 / 1 |
| 2026-10-18 | $5.59 | $164,607,333 | 2 / 1 |
| 2026-10-19 | $5.59 | $164,607,333 | 2 / 1 |
| 2026-10-20 | $5.59 | $164,607,333 | 2 / 1 |
| 2026-10-21 | $5.59 | $164,607,333 | 2 / 1 |
| 2026-10-22 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-23 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-24 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-25 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-26 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-27 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-28 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-29 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-30 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-10-31 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-11-01 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-11-02 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-11-03 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-11-04 | $5.59 | $164,607,333 | 2 / 2 |
| 2026-11-05 | $5.59 | $164,607,333 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 1 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.